Financial Performance - The company's operating revenue for Q1 2022 was CNY 378,802,067.82, representing a year-on-year increase of 27.34%[5] - The net profit attributable to shareholders for Q1 2022 was CNY 30,099,157.69, showing a significant increase of 178.83% compared to the same period last year[5][10] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 24,671,760.18, reflecting a year-on-year growth of 159.59%[5][10] - Basic and diluted earnings per share for Q1 2022 were both CNY 0.18, marking a 157.14% increase year-on-year[6][11] - Net profit reached RMB 30.10 million, representing a significant growth of 178.83% year-on-year[15] - The company reported a total comprehensive income of ¥30,099,157.69 for Q1 2022, compared to ¥10,794,686.34 in Q1 2021[24] Cash Flow - The net cash flow from operating activities was CNY 4,449,521.57, which is an increase of 106.76% compared to the previous year[6][11] - Cash flow from operating activities generated a net amount of ¥4,449,521.57, recovering from a negative cash flow of ¥65,775,368.04 in the same period last year[27] - The net cash flow from investing activities was -5,355,679.17 for Q1 2022, compared to -23,961,890.09 in the previous period[28] - The net cash flow from financing activities was 135,378,223.59, while the previous period showed a net outflow of -154,182,997.93[28] - The net increase in cash and cash equivalents was 134,472,065.99, contrasting with a decrease of -243,920,256.06 in the prior period[28] - The company reported a significant increase in cash and cash equivalents compared to the previous period[28] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,933,319,649.42, up 7.58% from the end of the previous year[6] - Total assets as of March 31, 2022, were RMB 2.93 billion, an increase from RMB 2.73 billion at the end of 2021[19] - The total liabilities as of Q1 2022 amounted to ¥1,114,254,117.35, compared to ¥937,586,349.47 in the previous year[20] - Current liabilities totaled RMB 569.30 million, compared to RMB 476.75 million in the previous year[19] - Total equity attributable to shareholders reached ¥1,819,065,532.07, up from ¥1,788,954,640.62 in Q1 2021[20] Business Expansion - The company has expanded its business into lithium hexafluorophosphate, which has significantly boosted profits[10] - The company sold 122.35 tons of lithium hexafluorophosphate in Q1 2022[15] - A total investment of RMB 700 million is planned for a new lithium hexafluorophosphate project in Ganzhou, Jiangxi, with multiple production lines under development[16] - The second production line with an annual capacity of 3,000 tons is set to be installed by April 2022, while a third line of 5,000 tons is expected to be completed by July 2022[16] - The company has successfully developed samples for lithium hexafluorophosphate packaging barrels and valves[16] Government Support - The company received government subsidies amounting to CNY 5,961,375.84, which contributed to the non-recurring gains[7] Research and Development - Research and development expenses for Q1 2022 totaled ¥15,699,404.80, an increase from ¥13,012,335.00 in Q1 2021[23] Other Financial Metrics - The return on equity (ROE) increased by 1.03 percentage points to 1.67%[6] - The gross profit margin increased by 46.2%, primarily due to stable production from the lithium hexafluorophosphate project[15] - The company did not apply the new accounting standards starting from 2022[28]
深圳新星(603978) - 2022 Q1 - 季度财报